30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Entia Biosciences Inc (ERGO)

Track

Stock chart
Ticker: ERGO Exchange: OTC
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
ANDRES DEVIN D.
COO, VP, Sales and Marketing
1 purchase — total 128,892 USD
Buy 25 Sep 2014
Value US$4,654,503.82 | Price 423.79 | Shares 25,890
Buy 25 Sep 2014
Value US$3,633,025.68 | Price 150.32 | Shares 65,651
Buy 17 Dec 2013
Value US$23,751.90 | Price 0.38 | Shares 62,505
Buy 17 Dec 2013
Value US$19,793.82 | Price 0.38 | Shares 52,089
Buy 12 Jul 2013
Value US$50,000.02 | Price 0.38 | Shares 131,579
Buy 11 Jun 2013
Value US$50,000.02 | Price 0.38 | Shares 131,579
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2014-11-12 2014-09-25 B Purchase ANDRES DEVIN D.

COO, VP, Sales and Marketing

Officer
25,890 +47.1%
423.79
US$4,654,504 		25,890 +47.1% 423.79 US$4,654,504
2014-11-12 2014-09-25 B Purchase HAUSMAN MARVIN S MD

President, CEO, Acting CFO

Executive Director Large shareholder
65,651 -11.2%
150.32
US$3,633,026 		65,651 -11.2% 150.32 US$3,633,026
2013-12-19 2013-12-17 B Purchase HAUSMAN MARVIN S MD

President, CEO, Acting CFO

Executive Director Large shareholder
1,325 +36.4%
186.62
US$3,631,968 		1,325 +36.4% 186.62 US$3,631,968
2013-12-19 2013-12-17 B Purchase ANDRES DEVIN D.

COO, VP, Sales and Marketing

Officer
52,089 +35.0%
0.38
US$19,794 		52,089 +35.0% 0.38 US$19,794
2013-07-22 2013-07-12 B Purchase HAUSMAN MARVIN S MD

President, CEO, Acting CFO

Executive Director Large shareholder
131,579 +5.7%
0.38
US$50,000 		131,579 +5.7% 0.38 US$50,000
2013-06-12 2013-06-11 B Purchase ANDRES DEVIN D.

COO, VP, Sales and Marketing

Officer Large shareholder
131,579 +757.8%
0.38
US$50,000 		131,579 +757.8% 0.38 US$50,000
Explore more

More insider trading research around Entia Biosciences Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America